AstraZeneca forecast a likely slowdown in revenue growth this year, assuming a hit from China's coronavirus epidemic lasting up to a few months, although it added there had been limited disruption to its operations so far.
from Earnings https://ift.tt/3bEOdkQ
via IFTTT
No comments:
Post a Comment